Cargando…
Short- and Long-Term Survival of Metastatic Biliary Tract Cancer in the United States From 2000 to 2018
INTRODUCTION: Information about survival outcomes in metastatic biliary tract cancer (BTC) is sparse, and the numbers often quoted are based on reports of clinical trials data that may not be representative of patients treated in the real world. Furthermore, the impact of more widespread adoption of...
Autores principales: | Nghiem, Van, Wood, Sarah, Ramachandran, Rekha, Williams, Grant, Outlaw, Darryl, Paluri, Ravikumar, Kim, Young-il, Gbolahan, Olumide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668577/ https://www.ncbi.nlm.nih.gov/pubmed/37926828 http://dx.doi.org/10.1177/10732748231211764 |
Ejemplares similares
-
Time to treatment initiation and its impact on real‐world survival in metastatic colorectal cancer and pancreatic cancer
por: Gbolahan, Olumide, et al.
Publicado: (2022) -
Role of chemoradiation in gallbladder cancer—a single institution retrospective analysis
por: Paluri, Ravi Kumar, et al.
Publicado: (2023) -
Predictors of biliary atresia outcome: Saudi National Study (2000 – 2018)
por: Abanemai, Mohammed, et al.
Publicado: (2023) -
The Epidemiology and Outcome of Biliary Atresia: Saudi Arabian National Study (2000–2018)
por: Al-Hussaini, Abdulrahman, et al.
Publicado: (2022) -
Efficacy and safety of nivolumab for metastatic biliary tract cancer
por: Gou, Miaomiao, et al.
Publicado: (2019)